Richard Duke

Dr. Duke is Acting CEO and Chairman of the Board of Aurora Oncology and has an impressive track record in bringing basic science discoveries from the lab to the clinic. He was a founder of a number of successful startup biotechnology companies including GlobeImmune, and ApopLogic, and heads the University of Colorado REACH program.